Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmu...

by Martina Ott, Erika Avendaño-Guzmán, Evelyn Ullrich, Carolin Dreyer, Judith Strauss, Markus Harden, Margarete Schön, Michael P. Schön, Günter Bernhardt, Christine Stadelmann, Christiane Wegner, Wolfgang Brück, Stefan Nessler
Published 2019-02-01